Nicotinamide as potential biomarker for alzheimer s disease: a translational study based on metabolomics

HIGHLIGHTS

  • who: . et al. from the Universitat de Lleida, Spain University of Chile, Chile have published the article: Nicotinamide as potential biomarker for Alzheimer s disease: A translational study based on metabolomics, in the Journal: (JOURNAL)
  • what: This analysis showed that only the higher levels of Nam are associated with a later conversion to dementia (hazard ratio (HR) 0.73, p=0.04). The authors focused the analysis on plasma because it might offer a promising alternative for biomarker in blood. The authors are aware that this study has also limitations. The study provides additional supporting . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?